Population-Based Study of Islet Cell Carcinoma
James C. Yao(The University of Texas MD Anderson Cancer Center), Douglas B. Evans(The University of Texas MD Anderson Cancer Center)
Cited by 338
Related Papers
Phase 3 Trial of <sup>177</sup> Lu-Dotatate for Midgut Neuroendocrine Tumors
|New England Journal of Medicine|2017|3.2k
Fruquintinib versus placebo in patients with refractory metastatic colorectal cancer (FRESCO-2): an international, multicentre, randomised, double-blind, phase 3 study
|The Lancet|2023|319
Perioperative nivolumab monotherapy versus nivolumab plus ipilimumab in resectable hepatocellular carcinoma: a randomised, open-label, phase 2 trial
|The Lancet. Gastroenterology & hepatology|2022|255
Localized Adenocarcinoma of the Pancreas: The Rationale for Preoperative Chemoradiation
|The Oncologist|2002|78
Molecular Profiling of Hepatocellular Carcinoma Using Circulating Cell-Free DNA
|Clinical Cancer Research|2019|76